UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. ____)*
Meridian Medical Technologies, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
589658103
- --------------------------------------------------------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 9 pages
<PAGE>
SCHEDULE 13G
- ---------------------------------- ----------------------------------------
CUSIP No. 589658103 Page 2 of 9 Pages
----------- ------- --------
- ---------------------------------- ----------------------------------------
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dillon, Read Holding Inc.
I.R.S. No. 13-3634771
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |_|
N/A
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF None
SHARES ----------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 188,225
REPORTING ----------------------------------------------------
PERSON WITH 7 SOLE DISPOSITIVE POWER
None
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
188,225
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Dillon, Read Holding Inc. disclaims beneficial ownership of
188,225 shares attributed to it through its ownership of
Dillon, Read Inc.
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (See Instructions) |_|
N/A
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.1
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (See Instructions)
HC
- -------------------------------------------------------------------------------
Page 2 of 9 Pages
<PAGE>
SCHEDULE 13G
- ---------------------------------- ----------------------------------------
CUSIP No. 589658103 Page 3 of 9 Pages
----------- ------- --------
- ---------------------------------- ----------------------------------------
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dillon, Read Inc.
I.R.S. No. 13-3404336
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |_|
N/A
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF None
SHARES ----------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 188,225
REPORTING ----------------------------------------------------
PERSON WITH 7 SOLE DISPOSITIVE POWER
None
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
188,225
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Dillon, Read Inc. disclaims beneficial ownership of
188,225 shares attributed to it through its ownership of
Dillon, Read & Co. Inc.
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (See Instructions) |_|
N/A
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.1
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (See Instructions)
HC
- -------------------------------------------------------------------------------
Page 3 of 9 Pages
<PAGE>
SCHEDULE 13G
- ---------------------------------- ----------------------------------------
CUSIP No. 589658103 Page 4 of 9 Pages
----------- ------- --------
- ---------------------------------- ----------------------------------------
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dillon, Read & Co. Inc.
I.R.S. No. 13-1939216
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |_|
N/A
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Connecticut
- -------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF None
SHARES ----------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 188,225
REPORTING ----------------------------------------------------
PERSON WITH 7 SOLE DISPOSITIVE POWER
None
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
188,225
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
The reporting person reports 188,225 shares held for managed accounts
and the reporting person disclaims beneficial interest in such shares.
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (See Instructions) |_|
N/A
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.1
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (See Instructions)
BD
- -------------------------------------------------------------------------------
Page 4 of 9 Pages
<PAGE>
Page 5 of 9 Pages
Item 1(a). Name of Issuer:
Meridian Medical Technologies, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
10240 Old Columbia Road
Columbia, Maryland 21046
Item 2(a). Name of Person Filing:
Dillon, Read Holding Inc.
Item 2(b). Address of Principal Business Office, or, if none, Residence:
535 Madison Avenue
New York, New York 10022
Item 2(c). Place of Organization:
Delaware
Item 2(d). Title of Class of Securities:
Common Stock
Item 2(e). CUSIP Number:
589658103
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or
13d-2(b), check whether the person filing is a:
(a) [ ] Broker or Dealer registered under Section 15 of the Act
(b) [ ] Bank as defined in Section 3(a)(6) of the Act
(c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act
(d) [ ] Investment Company registered under Section 8 of the
Investment Company Act
(e) [ ] Investment Adviser registered under Section 203 of the
Investment Advisers Act of 1940
(f) [ ] Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of
1974 or Endowment Fund; see Section 240.13d-1(b)(1)(ii)(F)
<PAGE>
Page 6 of 9 Pages
(g) [X] Parent Holding Company, in accordance with Section
240.13d-1(b)(1)(ii)(G) (Note: See Item 7)
(h) [ ] Group, in accordance with Section 240.13d-1(b)(1)(ii)(H)
Item 4. Ownership:
If the percent of the class owned, as of December 31 of the
year covered by the statement, or as of the last day of any
month described in Rule 13d-1(b)(2), if applicable, exceeds
five percent, provide the following information as of that
date and identify those shares which there is a right to
acquire.
(a) Amount Beneficially Owned:
188,225
(b) Percent of Class:
6.1
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: None
(ii) shared power to vote or to direct the vote: 188,225
(iii) sole power to dispose or to direct the disposition
of: None
(iv) shared power to dispose or to direct the disposition
of: 188,225
Item 5. Ownership of Five Percent or Less of a Class:
If this statement is being filed to report the fact that as of
the date hereof the reporting person has ceased to be the
beneficial owner of more that five percent of the class of
securities, check the following [ ].
Item 6. Ownership of More than Five Percent on Behalf of Another Person:
N/A
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company:
See Exhibit A
<PAGE>
Page 7 of 9 Pages
Item 8. Identification and Classification of Members of the Group:
N/A
Item 9. Notice of Dissolution of Group:
N/A
Item 10. Certification:
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the
ordinary course of business and were not acquired for the purpose
of and do not have the effect of changing or influencing the
control of the issuer of such securities and were not acquired in
connection with or as a participant in any transaction having such
purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief I certify that the information set forth in this statement is true,
complete and correct.
Dated: February 11, 1997 Dillon, Read Holding Inc.
By /s/ David W. Niemiec
-----------------------
Name: David W. Niemiec
Title: Vice Chairman
<PAGE>
Page 8 of 9 Pages
Exhibit A
RELEVANT SUBSIDIARIES (Item 7)
Item 3
Identity Classification
1. Dillon, Read Inc. (g) Holding Company
2. Dillon, Read & Co. Inc. (a) Broker-Dealer
Dillon, Read Holding Inc. owns Dillon, Read Inc., the 100% owner of
Dillon, Read & Co. Inc.
<PAGE>
Page 9 of 9 Pages
Exhibit B
The undersigned all hereby agree in writing that
Schedule13G, filed with the Securities and Exchange Commission by DILLON, READ
HOLDING INC., and containing the information required by the Schedule 13G with
respect to beneficial ownership of the same shares of the Common Stock of
Meridian Medical Technologies, Inc. is jointly filed on behalf of each DILLON,
READ HOLDING INC., DILLON, READ INC. and DILLON, READ & CO. INC.
DILLON, READ HOLDING INC.
By:/s/ David W. Niemiec
----------------------------
Name: David W. Niemiec
Title: Vice Chairman
DILLON, READ INC.
By:/s/ David W. Niemiec
----------------------------
Name: David W. Niemiec
Title: Secretary
DILLON, READ & CO. INC.
By:/s/ David W. Niemiec
----------------------------
Name: David W. Niemiec
Title: Vice Chairman
